LiverPAL: A Trial of Inpatient Palliative Care for Patients With Advanced Liver Disease

Recruiting N/A Interventional Study
Liver Disease Chronic End Stage Liver DIsease Cirrhosis Cirrhosis, Liver Advanced Cirrhosis
No Placebo Group Every participant receives an active treatment — no one gets a placebo.
Ready to participate?

Review the details below, then apply to join this clinical trial.

At a Glance
Age
18 and older
Sex
Any
Study type
Interventional
Purpose
Supportive Care
Participants needed
200 (estimated)
Sponsor
Massachusetts General Hospital · Other
Think this trial could be right for you?

Answer a few quick questions to see if you may meet the eligibility requirements.

Check Your Eligibility
About This Trial

The goal of this clinical trial is to evaluate whether early integration of palliative care in the care of hospitalized patients with advanced liver disease (AdvLD) can improve patients' quality of life, physical symptoms, mood, and serious illness communication. Palliative care is a medical specialty focused on lessening (or "palliating") symptoms and assisting in coping with serious illness.

Trial Locations
Loading…

Loading trial locations…

Eligibility Criteria
Patient Inclusion Criteria: 1. Hospitalized patient with a diagnosis of advanced liver disease, defined as cirrhosis with one of the following (new or ongoing) within the prior six months from date of consent: * Ascites (requiring diuretics or serial large volume paracenteses) * Spontaneous …
Contacts

Grace Bizup, BA

617-724-1316

gbizup@mgh.harvard.edu

CONTACT

William Munroe, BA

617- 726-0161

wlmunroe@mgh.harvard.edu

CONTACT